Essential Pharmaceuticals

Focus: Essential Pharmaceuticals is a specialty pharma company headquartered in Raleigh, NC, focused on organ preservation and neurology therapeutics. The company operates with minimal public disclosure on scale and funding status.

Neurology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Essential Pharmaceuticals

AI assessmentNot Hiring

No open roles listed right now. Follow Essential Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

25 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

MANTA vascular closure device

Femoral Arteriotomy Closure

N/A

Clinical Trials (1)

NCT02908880MANTA Percutaneous Vascular Closure Device - The SAFE MANTA Study

N/A

Help build intelligence for Essential Pharmaceuticals

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Diverse pipeline spanning 20 clinical programs across neurology, vascular closure, and organ preservation—offering exposure to multiple therapeutic modalities and disease areas
Active development of repurposed and novel compounds (Epidiolex for blepharospasm, CBD/THC for essential tremor, electro-thermo-coagulation for wound healing) in Phase 1-3 stages
Specialty focus on organ preservation and niche neurological indications suggests smaller, agile team structure with potential for individual impact

Watch Out For

Pipeline data quality is severely compromised: includes non-pharmaceutical entries (condoms, aromatherapy, educational websites, supplement drinks), control arms listed as programs, and apparent clinical trial database noise, raising questions about data governance and operational rigor
Zero active job postings and no disclosed employee count, funding, revenue, or financial metrics suggest either stealth-mode operations or dormant status; impossible to assess financial stability or growth trajectory

Generated by Claude from Essential Pharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

MANTA Vascular Closure Device

Femoral Arteriotomy Closure

N/A

Clinical Trials (1)

NCT02521948Clinical Study to Evaluate the Safety and Performance of MANTA Vascular Closure Device

N/A

IMNCI

Mortality

N/A

Clinical Trials (1)

NCT00474981Impact of the Integrated Management of Neonatal and Childhood Illness Strategy on Neonatal and Infant Mortality

N/A